The effect of acitretin on moderate to severe plaque psoriasis

Journal of Clinical Dermatology

Volumn 36, Issue 9, 2007, Pages 592-593

  Zhang, Min ^a   Zhang, Yi Zhi ^a   Wang, Sheng ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Acitretin; Psoriasis

Indexed keywords

CHINESE DRUG; ETRETIN;

ADULT; ARTICLE; CHINESE MEDICINE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; MALE; PSORIASIS VULGARIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM;

EID: 35448940138     PISSN: 10004963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Schmitt J, Wozel G. The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis[J]. Dermatology, 2005, 210(3): 194-199.
2. Feldman SR, Krueger GG. Psoriasis assessment tools in clinical trials[J]. Ann Rheum Dis, 2005, (64 Suppl 2): ii65-ii68
3. Geiger JM. Efficacy of acitretin in severe psoriasis[J]. Skin Therapy Lett, 2003, 8(4): 1-3, 7.
4. Chinese source.
5. Lee CS, Koo J. A review of acitretin, a systemic retinoid for the treatment of psoriasis[J]. Expert Opin Pharmacother, 2005, 6(10): 1725-1734.
6. McClure SL, Valentine J, Gordon KB. Comparative tolerability of systemic treatments for plaque-type psoriasis[J]. Drug Saf, 2002, 25(13): 913-927.
7. Chinese source.
8. Shiklar R, Willian MK, Okun MM, et al. The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study[J]. Health Qual Life Outcomes, 2006, 27(4): 71.